Methods of treating inflammatory diseases
By administering anti-IL-23A antibodies at specific doses and intervals, the method effectively treats inflammatory diseases like psoriasis and psoriatic arthritis, offering improved clinical outcomes with reduced treatment burden.
JP2025060798AActive Publication Date: 2025-04-10BOEHRINGER INGELHEIM INT GMBH
Patent Information
- Application Number
- JP2024227224
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-10-01
- Filing Date
- 2024-12-24
- Publication Date
- 2025-04-10
- Estimated Expiration
- 2036-02-02
Smart Images
Figure 2025060798000014 
Figure 2025060798000015 
Figure 2025060798000016
Abstract
To provide methods for the treatment of inflammatory diseases utilizing anti-IL-23A antibodies.SOLUTION: A method for treating psoriasis or psoriatic arthritis comprises administering to a patient an anti-IL-23A antibody. The method comprises: a) administering an initial dose of the anti-IL-23A antibody to the patient; b) administering a first maintenance dose of the anti-IL-23A antibody to the patient 4 to 24 weeks, e.g., 4 to 12 weeks, e.g., 6 to 24 weeks, e.g., 6 to 12 weeks, after the initial dose is administered; and c) administering at least one additional maintenance dose to the patient 4 to 24 weeks, e.g., 4 to 12 weeks, e.g., 6 to 24 weeks, e.g., 6 to 12 weeks, after the first maintenance dose is administered.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Anti-IL-23 antibody
JP2014500009A